# Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome

Study · id `cardio:ct-nct02037412` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02037412](<https://clinicaltrials.gov/study/NCT02037412>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02037412

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 148 participants.

## Technical summary

Registry record NCT02037412. Randomized; no masking; primary purpose treatment. Start 2014-01 (registry gives no type); primary completion 2016-09-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 148 participants (enrolled count; ClinicalTrials.gov record NCT02037412, source copy `cardio:ctgov-nct02037412-2019-03-29`, retrieved 2026-10-31)
- Start date: 2014-01 (registry gives no type) (ClinicalTrials.gov record NCT02037412, source copy `cardio:ctgov-nct02037412-2019-03-29`, retrieved 2026-10-31)
- Primary completion: 2016-09-30 (actual) (ClinicalTrials.gov record NCT02037412, source copy `cardio:ctgov-nct02037412-2019-03-29`, retrieved 2026-10-31)
- Completion: 2016-09-30 (actual) (ClinicalTrials.gov record NCT02037412, source copy `cardio:ctgov-nct02037412-2019-03-29`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT02037412, source copy `cardio:ctgov-nct02037412-2019-03-29`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02037412-2019-03-29`, retrieved 2026-10-31)

## The registry's words

- Brief title: Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome
- Condition: Acute Coronary Syndrome
- Condition: Acute Myocardial Infarction
- Condition: Unstable Angina (Intermediate Coronary Syndrome)
- Intervention (Drug): Ticagrelor
- Intervention (Drug): Clopidogrel
- Lead sponsor: Yonsei University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Unstable angina (`cardio:unstable-angina`)
- Registry intervention name matches this record: Ticagrelor (`cardio:ticagrelor`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention is a member of this class by a sourced record link: P2Y12 inhibitors (drug class) (`cardio:p2y12-inhibitors`)
- Registry lists this organization as the lead sponsor: Yonsei University (`cardio:org-yonsei-university`)

## Provenance

Content hash: a17a9c8eb0e279fc8bb865e710fe2f648855cfd83239fbe179a492047c7a3f51
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
